Abnormal cisatracurium pharmacodynamics and pharmacokinetics among patients with severe aortic regurgitation during anesthetic induction

[1]  O. Akinseye,et al.  Aortic Valve Regurgitation: A Comprehensive Review. , 2017, Current problems in cardiology.

[2]  A. Gerlach,et al.  The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit , 2017, International journal of critical illness and injury science.

[3]  Xuemei Peng,et al.  Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period , 2017, British journal of clinical pharmacology.

[4]  M. Desai,et al.  Long-Term Outcomes in Patients With Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction. , 2016, Journal of the American College of Cardiology.

[5]  Jong Hwan Lee,et al.  Effective doses of cisatracurium in the adult and the elderly , 2016, Korean journal of anesthesiology.

[6]  Xuemei Peng,et al.  Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects , 2016, Drug Metabolism and Disposition.

[7]  M. Roberts,et al.  The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis. , 2012, British journal of clinical pharmacology.

[8]  D. Faulds,et al.  Cisatracurium Besilate , 1997, Drugs.

[9]  J. Halperin,et al.  Aortic regurgitation: disease progression and management , 2008, Nature Clinical Practice Cardiovascular Medicine.

[10]  V. Nkomo.  Indications for surgery for aortic regurgitation , 2003, Current cardiology reports.

[11]  D. Bevan,et al.  Concentration–Effect Relationship of Cisatracurium at Three Different Dose Levels in the Anesthetized Patient , 2001, Anesthesiology.

[12]  David F. Kisor,et al.  Clinical Pharmacokinetics of Cisatracurium Besilate , 1999, Clinical pharmacokinetics.

[13]  C. Diefenbach,et al.  Die klinische Pharmakologie von Cisatracurium , 1997, Der Anaesthesist.

[14]  C. Diefenbach,et al.  [The clinical pharmacology of cisatracurium]. , 1997, Der Anaesthesist.

[15]  D. Faulds,et al.  Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice. , 1997, Drugs.

[16]  R. Welch,et al.  The in vitro degradation of cisatracurium, the R, cis‐R′‐isomer of atracurium, in human and rat plasma , 1995, Clinical pharmacology and therapeutics.

[17]  Alan R. Brown,et al.  The Degradation and Metabolism of 51W89, the R,cis-R1,CIS Isomer of Atracurium, in Human and Rat Plasma , 1994 .

[18]  A. Yeung,et al.  Calculation of aortic regurgitation orifice area by Doppler echocardiography: an application of the continuity equation , 1992, British heart journal.